Transcutaneous vagus nerve stimulation (tVNS) enhances response selection during action cascading processes

European Neuropsychopharmacology

Volumn 25, Issue 6, 2015, Pages 773-778

  Steenbergen, Laura ^a   Sellaro, Roberta ^a   Stock, Ann Kathrin ^b   Verkuil, Bart ^a   Beste, Christian ^b   Colzato, Lorenza S ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Executive function; GABA; Norepinephrine; Vagus nerve stimulation

Indexed keywords

4 AMINOBUTYRIC ACID; NORADRENALIN;

ADULT; ARTICLE; BRAIN LEVEL; CLINICAL ARTICLE; CONTROL STRATEGY; CONTROLLED STUDY; FEMALE; GABAERGIC SYSTEM; HEART RATE; HUMAN; MALE; NEUROMODULATION; NORADRENERGIC SYSTEM; NORMAL HUMAN; PRIORITY JOURNAL; REACTION TIME; SINGLE BLIND PROCEDURE; TASK PERFORMANCE; TRANSCUTANEOUS VAGUS NERVE STIMULATION; VAGUS NERVE STIMULATION; ADOLESCENT; ANALYSIS OF VARIANCE; AUDITORY STIMULATION; BRAIN; DECISION MAKING; METABOLISM; PHYSIOLOGY; PROCEDURES; PSYCHOMOTOR PERFORMANCE; RANDOMIZED CONTROLLED TRIAL; TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION; VAGUS NERVE; YOUNG ADULT;

ACOUSTIC STIMULATION; ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; BRAIN; DECISION MAKING; FEMALE; GAMMA-AMINOBUTYRIC ACID; HEART RATE; HUMANS; JUDGMENT; MALE; NOREPINEPHRINE; PSYCHOMOTOR PERFORMANCE; REACTION TIME; SINGLE-BLIND METHOD; TRANSCUTANEOUS ELECTRIC NERVE STIMULATION; VAGUS NERVE; YOUNG ADULT;

EID: 84930277181     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2015.03.015     Document Type: Article

References (40)

1. Borovikova L.V., Ivanova S., Zhang M., Yang H., Botchkina G.I., Watkins L.R., Tracey K.J. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000, 405(6785):458-462.
2. Bartus R.T., Dean R.L., Pontecorvo M.J., Flicker C. The cholinergic hypothesis: a historical overview, current perspective, and future directions. Ann. N. Y. Acad. Sci. 1985, 444:332-358.
3. Ben-Menachem E., Hamberger A., Hedner T., Hammond E.J., Uthman B.M., Slater J., Wilder B.J. Effects of vagus nerve stimulation on amino acids and other metabolites in the CSF of patients with partial seizures. Epilepsy Res. 1995, 20:221-227.
4. Beste C., Saft C. Action selection in a possible model of striatal medium spiny neuron dysfunction: behavioral and EEG data in a patient with benign hereditary chorea. Brain Struct. Funct. 2013, 220:221-228. 10.1007/s00429-013-0649-9.
5. Bestmann S., de Berker A.O., Bonaiuto J. Understanding the behavioural consequences of noninvasive brain stimulation. Trends Cognit. Sci. 2015, 19:13-20.
6. Colzato L.S., Hertsig G., van den Wildenberg W.P.M., Hommel B. Estrogen modulates inhibitory control in healthy human females: evidence from the stop-signal paradigm. Neuroscience 2010, 167:709-715. 10.1016/j.neuroscience.2010.02.029.
7. Colzato L.S., Kool W., Hommel B. Stress modulation of visuomotor binding. Neuropsychologia 2008, 46:1542-1548. 10.1016/j.neuropsychologia.2008.01.006.
8. Colzato L.S., Jongkees B.J., Sellaro R., van den Wildenberg W., Hommel B. Eating to stop: tyrosine supplementation enhances inhibitory control but not response execution. Neuropsychologia 2014, 62:398-402.
9. Colzato L.S., van den Wildenberg W., Hommel B. The genetic impact (C957T-DRD2) on inhibitory control is magnified by aging. Neuropsychologia 2013, 51:1377-1381.
10. Cristancho P., Cristancho M.A., Baltuch G.H., Thase M.E., O'Reardon J.P. Effectiveness and safety of vagus nerve stimulation for severe treatment-resistant major depression in clinical practice after FDA approval: outcomes at 1 year. J. Clin. Psychiatry 2011, 72:1376-1382.
11. Dietrich S., Smith J., Scherzinger C., Hofmann-Preiss K., Freitag T., Eisenkolb A., Ringler R. A novel transcutaneous vagus nerve stimulation leads to brainstem and cerebral activations measured by functional MRI/Funktionelle Magnetresonanztomographie zeigt Aktivierungen des Hirnstamms und weiterer zerebraler Strukturen unter transkutaner Vagusnervstimulation. Biomed. Tech./Biomed. Eng. 2008, 53(3):104-111.
12. Duncan J. The structure of cognition: attentional episodes in mind and brain. Neuron 2013, 80:35-50.
13. Duncan J. The multiple-demand (MD) system of the primate brain: mental programs for intelligent behaviour. Trends Cognit. Sci. 2010, 14:172-179.
14. Fallgatter A.J., Neuhauser B., Herrmann M.J., Ehlis A.C., Wagener A., Scheuerpflug P., Riederer P. Far field potentials from the brain stem after transcutaneous vagus nerve stimulation. J. Neural Transm. 2003, 110(12):1437-1443.
15. Galvin G.B. Stress and monoamines: a review. Neurosci. Biobehav. Rev. 1990, 9:233-243.
16. Glavin G.B. Stress and brain noradrenaline: a review. Neurosci. Biobehav. Rev. 1985, 9:233-243.
17. Kraus T., Hosl K., Kiess O., Schanze A., Kornhuber J., Forster C. BOLD fMRI deactivation of limbic and temporal brain structures and mood enhancing effect by transcuaneous vagus nerve stimulation. J. Neural Transm. 2007, 114:1485-1493.
18. Kraus T., Kiess O., Hösl K., Terekhin P., Kornhuber J., Forster C. CNS BOLD fMRI effects of sham-controlled transcutaneous electric nerve stimulation in the left outer auditory canal - a pilot study. Brain Stimul. 2013, 6:798-804. 10.1016/j.brs.2013.01.011.
19. Kreuzer P.M., Landgrebe M., Husser O., Resch M., Schecklmann M., Geisreiter F., Langguth B. Transcutaneous vagus nerve stimulation: retrospective assessment of cardiac safety in a pilot study. Front. Psychiatry 2012, 3:1-7. 10.3389/fpsyt.2012.00070.
20. Logan G.D., Cowan W.B. On the ability to inhibit thought and action: A theory of an act of control. Psychol. Rev. 1984, 91:295-327.
21. Marrosu F., Serra A., Maleci A., Puligheddu M., Biggio G., Piga M. Correlation between GABA(A) receptor density and vagus nerve stimulation in individuals with drug-resistant partial epilepsy. Epilepsy Res. 2003, 55:59-70. 10.1016/S0920-1211(03)00107-4.
22. Mayer E.A. Gut feelings: the emerging biology of gut-brain communication. Nat. Rev. Neurosci. 2011, 12(8):453-466.
23. Mückschel M., Stock A.K., Beste C. Psychophysiological mechanisms of interindividual differences in goal activation modes during action cascading. Cereb. Cortex 2014, 24:2120-2129. 10.1093/cercor/bht066.
24. Mulligan M.K., Wang X., Adler A.L., Mozhui K., Lu L., Williams R.W. Complex control of GABA (A) receptor subunit mRNA expression: variation, covariation, and genetic regulation. PloS One 2012, 7:e34586.
25. Nemeroff C.B., Mayberg H.S., Krahl S.E., Mcnamara J., Frazer A., Henry T.R., Brannan S.K. VNS therapy in treatment-resistant depression: clinical evidence and putative neurobiological mechanisms. Neuropsychopharmacology 2006, 31:1345-1355.
26. Peuker E.T., Filler T.J. The nerve supply of the human auricle. Clin. Anat. 2002, 15:35-37.
27. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., Dunbar G.C. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 1998, 59:22-23.
28. Raedt R., Clinckers R., Mollet L., Vonck K., El Tahry R., Wyckhuys T., Meurs A. Increased hippocampus noradrenaline is a biomarker for efficacy of vagus nerve stimulation in a limbic seizure model. J. Neurochem. 2011, 117:461-469. 10.1111/j.1471-4159.2011.07214.x.
29. Roosevelt R.W., Smith D.C., Clough R.W., Jensen R.A., Browning R.A. Increased extracellular concentrations of norepinephrine in cortex and hippocampus following vagus nerve stimulation in the rat. Brain Res. 2006, 1119:124-132. 10.1016/j.brainres.2006.08.048.
30. Stöber G., Nöthen M.M., Pörzgen P., Brüss M., Bönisch H., Knapp M., Propping P. Systematic search for variation in the human norepinephrine transporter gene: identification of five naturally occurring missense mutations and study of association with major psychiatric disorders. Am. J. Med. Genet. 1996, 67:523-532.
31. Stock A.K., Blaszkewicz M., Beste C. Effects of binge drinking on action cascading processes: an EEG study. Arch. Toxicol. 2014, 88:475-488. 10.1007/s00204-013-1109-2.
32. Stock A.K., Arning L., Epplen J.T., Beste C. DRD1 and DRD2 genotypes modulate processing modes of goal activation processes during action cascading. J. Neurosci. 2014, 34:5335-5341.
33. Treiman D.M. GABAergic mechanisms in epilepsy. Epilepsia 2001, 42:8-12.
34. van Leusden J.W.R., Sellaro R., Colzato L.S. Transcutaneous vagal nerve stimulation (tVNS): a new neuromodulation tool in healthy humans?. Front. Psychol. 2015, 6:102.
35. Ventureyra E.C. Transcutaneous vagus nerve stimulation for partial onset seizure therapy. Childs Nerv. Syst. 2000, 16(2):101-102.
36. Verbruggen F., Schneider D.W., Logan G.D. How to stop and change a response: the role of goal activation in multitasking. J. Exp. Psychol. Hum. 2008, 34:1212-1228.
37. Vonck K., Raedt R., Naulaerts J., De Vogelaere F., Thiery E., Van Roost D., Boon P. Vagus nerve stimulation. . . 25 years later! What do we know about the effects on cognition?. Neurosci. Biobehav. Rev. 2014, 45:63-71. 10.1016/j.neubiorev.2014.05.005.
38. Watanabe H., Shimizu H., Matsumoto K. Acetylcholine release detected by trans-striatal dialysis in freely moving rats correlates with spontaneous motor activity. Life Sci. 1990, 47:829-832.
39. Yildiz A., Quetscher C., Dharmadhikari S., Chmielewski W., Glaubitz B., Schmidt-Wilcke T., Beste C. Feeling safe in the plane: neural mechanisms underlying superior action control in airplane pilot trainees-a combined EEG/MRS study. Hum. Brain Mapp. 2014, 35:5040-5051.
40. Yildiz A., Wolf O.T., Beste C. Stress intensifies demands on response selection during action cascading processes. Psychoneuroendocrinology 2014, 42:178-187.